Defining Treatment Response as Measured by PRO Instruments
View Presentation *Laurie Burke, FDA Keywords: Patient Reported Outcomes, Responder Analyses Laurie Burke, from the FDA (Study Endpoints and Labeling, OND) has worked extensively in the development of the PRO draft guidance document. Her presentation will introduce the PRO guidance document and will then discuss the particular focus for this session. Of specific interest is the definition and analysis of treatment response as measured by PRO instruments.
|
Key Dates
-
April 30 - May 22, 2013
Invited Abstract Submission Open -
June 4, 2013
Online Registration Opens -
August 9 - August 23, 2013
Invited Abstract Editing -
August 23, 2013
Short Course materials due from Instructors -
August 26, 2013
Housing Deadline -
September 9, 2013
Cancellation Deadline and Registration Closes @ 11:59 pm EDT -
September 16 - September 18, 2013
Marriott Wardman Park, Washington, DC